interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Desmopressin Acetate

Generic competition · all medicines · read 12 November 2026

Is there a generic of Desmopressin Acetate, and who makes it?

Desmopressin Acetate appears in 6 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 12 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came between 9.8 and 21.3 years after the first brand approval. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Desmopressin Acetate6 dosage-form groups in the Orange Book
12generic makers listed
  1. Desmopressin Acetate appears in 6 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 12 generic makers listed as marketed across them.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Where both are dated, the first generic approval came between 9.8 and 21.3 years after the first brand approval.
  4. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

Four or more generic makers listed

Brand listed as marketed: Ddavp. 5 generic makers with 10 generic products listed as marketed; the first generic approval is dated 1 July 2005.

1995200020052010201520202025203005brand 1995Apotex Inc, first approval 7 March 2006Heritage Pharma Labs Inc, first approval 26 May 2017Abhai Llc, first approval 28 January 2019Novast Laboratories Ltd, first approval 6 June 2019Aurobindo Pharma Ltd, first approval 21 March 2024data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Apotex Inc7 March 20062
Heritage Pharma Labs Inc26 May 20172
Abhai Llc28 January 20192
Novast Laboratories Ltd6 June 20192
Aurobindo Pharma Ltd21 March 20242

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Injectable, Injection

Four or more generic makers listed

Brand listed as marketed: Ddavp. 6 generic makers with 9 generic products listed as marketed; the first generic approval is dated 15 October 1997.

1980198519901995200020052010201520202025203006brand 1984Meitheal Pharmaceuticals Inc, first approval 15 October 1997Sagent Pharmaceuticals Inc, first approval 22 August 2017Ubi Pharma Inc, first approval 14 February 2020Dr Reddys Laboratories Ltd, first approval 19 August 2022Gland Pharma Ltd, first approval 16 November 2022Caplin Steriles Ltd, first approval 27 February 2026data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Meitheal Pharmaceuticals Inc15 October 19971
Sagent Pharmaceuticals Inc22 August 20172
Ubi Pharma Inc14 February 20202
Dr Reddys Laboratories Ltd19 August 20221
Gland Pharma Ltd16 November 20222
Caplin Steriles Ltd27 February 20261

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Spray, Metered, Nasal

One to three generic makers listed

Every brand product here is listed as discontinued. 2 generic makers with 2 generic products listed as marketed; the first generic approval is dated 25 January 1999.

198519901995200020052010201520202025203002brand 1989Apotex Inc, first approval 27 January 2005Zydus Pharmaceuticals Usa Inc, first approval 3 October 2017data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Apotex Inc27 January 20051
Zydus Pharmaceuticals Usa Inc3 October 20171

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Solution, Nasal

Nothing listed as marketed

Every brand product here is listed as discontinued. No generic is listed as marketed (1 generic product listed as discontinued).

19901995200020052010201520202025203001brand 1990data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Tablet, Sublingual

Nothing listed as marketed

Every brand product here is listed as discontinued. No generic is listed as marketed.

201520202025203001brand 2018data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Solution, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Desmoda. No generic is listed as marketed.

20202025203020352040204501brand 2026data datePatent 12343372 listed to expire 3 April 2044Patent 12214010 listed to expire 3 April 2044
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 3 April 2044Patent 12343372 drug product
  • 3 April 2044Patent 12214010 drug product

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.